Cooper Companies | COO - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Bausch Health Companies USD 6.52B 544M 2026-06
Baxter International USD 6.99B 142M 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dentsply International USD 1.93B 83M 2026-06
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
Haemonetics USD 810.83M 24.05M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.79B 716M 2026-03
Merit Medical Systems USD 1.11B 10.46M 2026-06
Novartis USD 26.61B 3.85B 2026-03
ResMed USD 4.32B 260.68M 2026-06
STAAR Surgical USD 342.35M 29.96M 2026-06
Steris USD 2.45B 51.2M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
Utah Medical Products USD 100.38M 2.64M 2026-03
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06